Mycronic AB (publ), Interim report January-September 2015


Third quarter July-September 2015

  · Order intake was SEK 559 (842) million
  · Net sales were SEK 605 (338) million
  · EBIT was SEK 262 (37) million
  · Earnings per share were SEK 2.33 (0.31)

Interim period January-September 2015

  · Order intake was SEK 1,341 (1,410) million
  · Net sales were SEK 1,194 (819) million
  · EBIT was SEK 289 (45) million
  · Earnings per share were SEK 2.52 (0.34)

Outlook
The Board’s assessment remains that sales in 2015 will be in the span SEK 1,650
-1,750 million.

Strong performance throughout the Group
“Healthy growth characterized the third quarter and the year’s first nine months
as regards sales and gross margins within both business areas. Adjusted for
currency effects, sales growth was 30 percent. The delivery of an advanced
display mask writer contributed significantly to the operating profit. The order
backlog remained strong after this mask writer delivery and was SEK 849 million
at the end of the quarter, exceeding last year by more than SEK 100 million.
Another advanced mask writer will be delivered during the fourth quarter," says
Lena Olving, CEO and President of Mycronic AB.
Mycronic’s launches of production solutions for effective electronics production
has led to increased demand within both of Mycronic’s business areas,
strengthening the company's market and financial positions. In nine months,
Mycronic has received orders for a total of seven mask writers for different
applications. The company's replacement offering for customers with older mask
writers for display applications has been well received with three orders thus
far this year.
Mycronic's investments in product development within existing product areas are
now complemented with efforts supporting major technological leaps within SMT.
By widening the product offering to include other segments, opportunities are
created for a position shift, which is in line with the company's strategy for
growth.
"Besides maintaining and developing our existing offering, we are investing in
product development for new needs and new markets within SMT. This includes both
new geographic markets and new product segments. We will ensure the development
of an attractive product offering which corresponds to customers' high demands
for effective electronics production within segments where
we have not traditionally been active. To this end, we entered into a
partnership with a high-tech engineering company in Asia during the third
quarter, increasing the pace in the execution of our product development
strategy within SMT. Through this partnership, we complement our unique
competence with specific technology and market competence for new customer
requirements,"
says Lena Olving.
Mycronic’s assessment is that costs for these efforts will be high for a number
of years to come. It is beneficial to do this now while the Group is
experiencing both strong sales and a good profit. These opportunities for unique
activities clearly confirm the logic behind the Mycronic merger of two companies
in 2009, both of which are active within different areas of the electronics
industry.

Contacts at Mycronic:
Lena Olving
President and CEO
+46 8 - 638 52 00
lena.olving@mycronic.com

Per Ekstedt
CFO
+46 8 - 638 52 00
per.ekstedt@mycronic.com

About Mycronic
Mycronic AB is a high-tech Swedish company engaged in developing, manufacturing
and marketing of production solutions to the electronics industry. Mycronic
headquarters are located in Täby, north of Stockholm and the Group has
subsidiaries in China, France, Germany, Japan, Singapore, South Korea, Taiwan,
the Netherlands, United Kingdom and the US. For more information, see the
company website www.mycronic.com.
Mycronic AB (publ) is listed on NASDAQ Stockholm, Mid Cap: MYCR.

Attachments

10200959.pdf